Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ANNA MALOVANNAYA and MEENAKSHI ANURAG.
ANNA MALOVANNAYA
Connection Strength
0.219
MEENAKSHI ANURAG
  1. Kinase inhibitor pulldown assay (KiP) for clinical proteomics. Clin Proteomics. 2024 Jan 16; 21(1):3.
    View in: PubMed
    Score: 0.059
  2. Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer. Cancer Res. 2023 10 02; 83(19):3237-3251.
    View in: PubMed
    Score: 0.058
  3. Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins. Cancer Res Commun. 2023 08; 3(8):1551-1563.
    View in: PubMed
    Score: 0.057
  4. Microscaled proteogenomic methods for precision oncology. Nat Commun. 2020 Jan 27; 11(1):532.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.